66. IgA腎症 IgA nephropathy Clinical trials / Disease details

臨床試験数 : 275 / 薬物数 : 258 - (DrugBank : 82) / 標的遺伝子数 : 36 - 標的パスウェイ数 : 140

11 trials found

diseases per page:

Showing 1 to 10 of 11 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04833374 (ClinicalTrials.gov)	May 24, 2021	4/4/2021	Steroids Therapy in IgA Nephropathy With Crescents	Effect and Security of Steroids Therapy for Patients of IgA Nephropathy With Crescents : A Prospecti ...	IgA Nephropathy	Drug: Methylprednisolone	Sixth Affiliated Hospital, Sun Yat-sen University	NULL	Recruiting	14 Years	65 Years	All	200	Phase 3	China
2	EUCTR2016-004507-31-FR (EUCTR)	27/01/2017	02/02/2017	N/A	N/A - TIGER	MedDRA version: 19.1;Level: PT;Classification code 10021263;Term: IgA nephropathy;System Organ Clas ...	Trade Name: METHYLPREDNISOLONE MYLAN Générique Product Name: METHYLPREDNISOLONE MYLAN Générique INN or P ...	ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	122	Phase 3	France
3	NCT02647255 (ClinicalTrials.gov)	March 2016	21/12/2015	Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy	Randomized Trial of Plasma Exchange as Adjunctive Therapy for Severe Crescentic GlomerUlonephritis o ...	Glomerulonephritis, IGA;Kidney Diseases;Acute Renal Insufficiency;Rapidly Progressive Glomerulonephr ...	Procedure: Plasma Exchange (PE);Drug: Methylprednisolone pulse	Peking University First Hospital	NULL	Terminated	14 Years	65 Years	All	10	Phase 2/Phase 3	China
4	NCT02160132 (ClinicalTrials.gov)	June 2014	3/6/2014	A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Chan ...	Effect and Security of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Cha ...	Glomerulonephritis, IGA;Peripapillary Crescent;Necrosis;Steroid Nephropathy	Drug: Methylprednisolone (intravenously in the 1st-2nd-3rd month );Drug: Methylprednisolone (intraveno ...	Sun Yat-sen University	NULL	Recruiting	14 Years	65 Years	Both	180	Phase 2	China
5	NCT01560052 (ClinicalTrials.gov)	May 5, 2012	15/3/2012	Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)	Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study Low Dose Study	IgA Glomerulonephritis	Drug: methylprednisolone;Drug: Placebo	The George Institute	Peking University First Hospital	Completed	18 Years	N/A	All	503	N/A	Australia;Canada;China;Hong Kong;India;Malaysia
6	ChiCTR-TRC-09000607	2008-12-01	2009-11-28	Observation for Efficacy of methylprednisoloneand combined therapy of methylprednisoloneand mycophen ...	Efficacy Observation of methylprednisoloneand combined therapy of methylprednisoloneand mycophenolat ...	IgA nephropathy	A:Methylprednisolone0.4mg/kg * 8 weeks, reduction to 5mg / d to maintain, MMF0.75 bid * 6 months aft ...	Zhongshan Hospital of Fudan University	NULL	Completed	18	70	Both	A:40;B:40;		China
7	EUCTR2007-000871-41-DE (EUCTR)	24/01/2008	27/11/2007	Supportive versus Immunosuppressive Therapy for the treatment Of Progressive IgA Nephropathy - STOP ...	Supportive versus Immunosuppressive Therapy for the treatment Of Progressive IgA Nephropathy - STOP ...	IgA nephropathy (IgAN) as the most common type of glomerulonephritis. MedDRA version: 16.1;Level: PT ...	Product Name: Azathioprine INN or Proposed INN: AZATHIOPRINE Product Name: Cyclophosphamid INN or Propo ...	RWTH Aachen	NULL	Not Recruiting			Female: yes Male: yes	148		Germany
8	NCT00657059 (ClinicalTrials.gov)	September 2007	8/4/2008	Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)	A Prospective, Multicenter, Randomized Controlled Trial of Mycophenolate Mofetil (MMF) in Patients W ...	IgA Nephropathy	Drug: irbesartan;Drug: methylprednisolone (MP) or prednisone (pred);Drug: mycophenolate mofetil (MMF)	Sun Yat-sen University	NULL	Completed	14 Years	60 Years	All	151	Phase 3	China
9	JPRN-UMIN000000593	2006/11/01	05/02/2007	Randomized controlled trial of mizoribine for progressive IgA nephropathy	Randomized controlled trial of mizoribine for progressive IgA nephropathy - Randomized controlled tr ...	IgA nephropathy with moderate to severe histological alterations	Methylprednisolonepulse therapy followed by oral prednisoloneadministration Methylprednisolonepulse t ...	West Japan Study Group for Therapy of IgA Nephropathy	NULL	Complete: follow-up complete	15years-old	60years-old	Male and Female	120	Not selected	Japan
10	NCT01392833 (ClinicalTrials.gov)	December 1999	5/7/2011	Steroids and Azathioprine in Advanced IgAN	Steroids and Azathioprine in Early and Advanced IgA Nephropathy: Amendments to a Prospective Randomi ...	IgA Nephropathy;Chronic Kidney Disease	Drug: methylprednisolone;Drug: azathioprine;Drug: prednisone	A. Manzoni Hospital	NULL	Completed	16 Years	70 Years	Both	46	Phase 3	NULL

First Previous1 2Next Last